BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2897208)

  • 1. Platelet vinculin: a substrate of activated factor XIII.
    Asijee GM; Muszbek L; Kappelmayer J; Polgár J; Horváth A; Sturk A
    Biochim Biophys Acta; 1988 Jun; 954(3):303-8. PubMed ID: 2897208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation.
    Serrano K; Devine DV
    Thromb Haemost; 2002 Aug; 88(2):315-20. PubMed ID: 12195706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinculin is a permanent component of the membrane skeleton and is incorporated into the (re)organising cytoskeleton upon platelet activation.
    Asijee GM; Sturk A; Bruin T; Wilkinson JM; Ten Cate JW
    Eur J Biochem; 1990 Apr; 189(1):131-6. PubMed ID: 2110061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function.
    Muszbek L; Adány R; Mikkola H
    Crit Rev Clin Lab Sci; 1996; 33(5):357-421. PubMed ID: 8922891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of vinculin to the platelet cytoskeleton during thrombin-induced aggregation.
    Asyee GM; Sturk A; Muszbek L
    Exp Cell Res; 1987 Feb; 168(2):358-64. PubMed ID: 3100318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative ability of plasma and tissue transglutaminases to use collagen as a substrate.
    Jeleńska MM; Fesüs L; Kopeć M
    Biochim Biophys Acta; 1980 Dec; 616(2):167-78. PubMed ID: 6111338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of thrombospondin as a substrate for factor XIII transglutaminase.
    Lynch GW; Slayter HS; Miller BE; McDonagh J
    J Biol Chem; 1987 Feb; 262(4):1772-8. PubMed ID: 2879842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of plasma factor XIII to thrombin-receptor activated human platelets.
    Nagy B; Simon Z; Bagoly Z; Muszbek L; Kappelmayer J
    Thromb Haemost; 2009 Jul; 102(1):83-9. PubMed ID: 19572072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Effects of Fibrinogen αC Mutations on the Ability of Factor XIII to Crosslink the Reactive αC Glutamines (Q237, Q328, Q366).
    Mouapi KN; Wagner LJ; Stephens CA; Hindi MM; Wilkey DW; Merchant ML; Maurer MC
    Thromb Haemost; 2019 Jul; 119(7):1048-1057. PubMed ID: 31055797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin.
    Achyuthan KE; Rowland TC; Birckbichler PJ; Lee KN; Bishop PD; Achyuthan AM
    Mol Cell Biochem; 1996 Sep; 162(1):43-9. PubMed ID: 8905624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrates of Factor XIII-A: roles in thrombosis and wound healing.
    Richardson VR; Cordell P; Standeven KF; Carter AM
    Clin Sci (Lond); 2013 Feb; 124(3):123-37. PubMed ID: 23075332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.
    Muszbek L; Adány R; Kávai M; Boda Z; Lopaciuk S
    Thromb Haemost; 1988 Apr; 59(2):231-5. PubMed ID: 2898817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of factor XIII activity in plasma.
    Katona É; Pénzes K; Molnár É; Muszbek L
    Clin Chem Lab Med; 2012 Feb; 50(7):1191-202. PubMed ID: 22850052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin.
    Wang DL; Annamalai AE; Ghosh S; Gewirtz AM; Colman RW
    Thromb Res; 1990 Jan; 57(1):39-57. PubMed ID: 2300924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet factor XIII is activated by calpain.
    Ando Y; Imamura S; Yamagata Y; Kitahara A; Saji H; Murachi T; Kannagi R
    Biochem Biophys Res Commun; 1987 Apr; 144(1):484-90. PubMed ID: 2883970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin is a substrate for blood coagulation factor XIIIa.
    Bale MD; Mosher DF
    Biochemistry; 1986 Sep; 25(19):5667-73. PubMed ID: 2877688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.